In research, there is often a tendency to focus on the brilliance of an idea. Yet when it comes to commercialisation, the most successful innovations rarely begin with a solution. They begin with a problem.

One of the strongest indicators of commercial potential is often evidence of people already trying to solve a problem themselves. Clinicians creating workarounds, adapting existing processes or finding alternative ways to manage challenges are often a sign that an unmet need exists.

The problem comes first
Identifying a problem is a good first step. Next up, work begins when researchers move beyond assumptions and engage directly with end users, clinicians, healthcare providers, industry partners and potential buyers. These conversations often reveal insights that cannot be uncovered in a laboratory or through technical development alone. In fact, some of the most successful projects are those that evolve significantly as a result of commercial discovery.

Why good ideas must learn to listen
Willingness to adapt and be flexible, is a crucial, but often overlooked aspect of commercialisation. Feedback from users can fundamentally reshape a product’s intended application, target customer or route to market. A pivot is not a sign that the original concept was flawed. Rather, it demonstrates commercial maturity and a commitment to solving a real-world problem in the most effective way possible. However, this is a difficult concept for some.

The danger of falling in love with your invention
Researchers are naturally invested in their ideas, and especially those who spend years developing and nurturing a product or solution. Yet, the true path of commercialisation is not one to walk alone. Collaboration and openness to change, are core parts of the journey. Bringing a health technology to market requires expertise spanning clinical practice, regulation, intellectual property, investment, reimbursement and business development. The projects most likely to succeed are often those that embrace diverse perspectives and welcome constructive criticism.

Failing faster, succeeding sooner
Perhaps the most important lesson is that commercial discovery is not designed to confirm assumptions. It is designed to test them. Meaningful validation sometimes produces uncomfortable answers, but those insights are invaluable. Identifying barriers early can save years of development effort and enable researchers to focus resources where they can have the greatest impact.

At its heart, the art of commercialisation is not about protecting an idea until it is perfect. It is about exposing that idea to the realities of the market as early as possible. By engaging with users, embracing feedback and remaining open to change, researchers can transform promising innovations into solutions capable of delivering meaningful benefits for healthcare systems and, ultimately, for patients.